CYTOGUIDE
Cytoguide is a new biotech company devoted to the development of combined drugs that target receptors on cells in pathological tissues for medical purposes by linking drug candidates and registered drugs with known pharmacological effects to targeting receptor-binding protein partners. The development of receptor-targeted therapeutics will focus on the macrophage specific receptor CD163, the most abundant transport receptor on macrophages. The company has the IP right for existing CD163 targeting technology as well as strong scientific experience and know-how to exploit the use of this receptor for drug therapy. The combined drugs are aimed to improve the treatment of monocyte/macrophage-related diseases including autoimmune disease, leukemia and infectious diseases.
CYTOGUIDE
Industry:
Biotechnology
Founded:
2007-01-01
Address:
Ã…rhus, Midtjylland, Denmark
Country:
Denmark
Website Url:
http://www.cytoguide.dk
Status:
Active
Contact:
45 28 99 22 82
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apache Mobile Non Scaleable Content Facebook Sharer ASP.NET IIS Sectigo SSL Sectigo Domain SSL Pinterest
Similar Organizations
Chronos Therapeutics
Chronos Therapeutics is a drug development company focused on the development of drugs for the treatment of age-related diseases.
IcanoMAB
IcanoMAB is a biotech company focusing on pre-clinical and clinical development for the treatment of cancer and other related diseases.
Current Employees Featured
Founder
Investors List
Lund University Bioscience
Lund University Bioscience investment in Funding Round - Cytoguide
More informations about "Cytoguide"
Cytoguide - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 45 28 99 22 82 Cytoguide is a new biotech company devoted to the development of combined drugs that …See details»
CYTOGUIDE ApS - 30921984 - Denmark - B2BHint
CYTOGUIDE ApS Danish company, Company number: 30921984, Incorporation Date Oct 23, 2007;, Address: Jørgen Brønlunds Vej 14, 8200 Aarhus NSee details»
Cytoguide Company Profile 2024: Valuation, Investors ... - PitchBook
Cytoguide General Information Description. Developer of combined drugs that target receptors on cells in pathological tissues. The company offers drugs that are aimed to improve the …See details»
CYTOGUIDE ApS :: Denmark :: OpenCorporates
Free and open company data on Denmark company CYTOGUIDE ApS (company number 30921984), Jørgen Brønlunds Vej 14, Aarhus N, 8200. Changes to our website — to find out …See details»
Cytoguide - Crunchbase Company Profile & Funding
Cytoguide is a biotech company that focuses on the development of combined drugs to treat monocyte- and macrophage-related diseases. Search Crunchbase. Start Free Trial . Chrome …See details»
Cytoguide: Contact Details and Business Profile - RocketReach
Cytoguide is a Drug Manufacturing & Research, Biotechnology, and Pharmaceuticals company located in Arhus, Central Jutland with 0 employees. Find top employees, contact details and …See details»
Cytoguide ApS:Company Profile & Technical Research,Competitor …
Cytoguide is a company that provides Receptor, Drug, CD163 and more. Cytoguide is headquartered in Denmark Midtjylland. Cytoguide was founded in 2007. and was founded by …See details»
CYTOGUIDE Trademark of Cytoguide ApS. Serial Number: …
TrademarkElite is the U.S. #1 Trademark Search and Registration Service :: CYTOGUIDE is a trademark and brand of Cytoguide ApS, , DK. This trademark application was filed with the …See details»
Cytoguide - VentureRadar
"Affinicon is a new biotech company devoted to the development of combined drugs that target receptors on cells in pathological tissues for medical purposes by linking drug candidates and …See details»
Cytoguide ApS - BioCentury Company Profiles - BCIQ
Jan 6, 2011 Cytoguide ApS - BioCentury Company Profiles for the biopharma industrySee details»
Cytoguide - Crunchbase
Cytoguide is a biotech company that focuses on the development of combined drugs to treat monocyte- and macrophage-related diseases. Search Crunchbase. Start Free Trial . Chrome …See details»
Cytoguide ApS - Products, Competitors, Financials, Employees ...
CytoGuide focuses on the development of two-component drugs that has the potential to maximise the effectiveness of a well-known Rheumatoid Arthritis treatment while drastically …See details»
Cytoguide ApS I Likvidation - Jørgen Brønlunds Vej 14, 8200
Cytoguide ApS I Likvidation Aarhus. See Google profile, Website and more for this business. 0.5 Cybo Score. Cytoguide ApS I Likvidation is working in Research, development and testing …See details»
Cytoguide - Funding, Financials, Valuation & Investors - Crunchbase
Jun 2, 2009 Cytoguide is a biotech company that focuses on the development of combined drugs to treat monocyte- and macrophage-related diseases. Search Crunchbase. ... How …See details»
Cytoguide ApS Company Profile, Financial and Strategic SWOT
Cytoguide ApS operates as a biotechnology company. It develops two-component drugs that target specific receptors on cells of the immune system, as well as solutions for the treatment …See details»
Cytoguide Asset Profile - Preqin
Founded in 2007 and based in Århus C, Denmark, Cytoguide develops pharmaceuticals that selectively bind receptors on cells in inflamed tissue. Current Investors Lund University ...See details»
Cytoguide - Company Profile - Tracxn
Oct 22, 2024 Cytoguide - Targeted drug development for macrophages using humanized antibodies for Autoimmune diseases. This company is not active anymore. Raised funding …See details»
CITCO 2.0 - sdu.dk
CITCO was established in 2020 as a close collaboration between researchers and clinicians from the Clinical Immunology Department and the Hematology Department at Odense University …See details»
Cytoguide - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Cytoguide is a biotech company that focuses on the development of combined drugs to treat monocyte- and macrophage-related diseases. Search Crunchbase. Start Free Trial . Chrome …See details»
Cytoguide - Turon medtech
Cytoguide has improved patient quality of care and created better working environments for healthcare providers worldwide. Its unique features, functions and quality has revolutionized …See details»